BROMFENAC 0.09%w/v IP + MOXIFLOXACIN 0.5%w/v IP + BENZALKONIUM CHLORIDE 0.02%v/v...

Belongs to ophthalmic eye medications for post-operative ocular inflammation and pain. A broad-spectrum bactericidal against a broad array of ocular pathogens. (Miller, 2008) Blocks the release of certain chemicals that cause pain and inflammation in the eyes. (Xiao Jing Wang, 2011) A suitable option for the rapid resolution of ocular pain after cataract surgery. (Hyung Cho, 2009) Rapidly diminishes ocular irritation, including burning and stinging in the treatment of postsurgical inflammation. (Hyung Cho, 2009) Exerts anti-inflammatory, analgesic, and anti-allergic effects and shows a good curative effect in treating postoperative inflammation of cataracts. (Chunyue Wang, 2020) Alleviates ocular postoperative pain, controls inflammation and prevents macular edema. (Seok Hyeon Song, 2020) A safe and effective agent for reducing and treating ocular inflammation and pain associated with cataract surgery. (Bonnie A Henderson & Group, 2011) An ophthalmic solution that is effective in treating the pain associated with infectious keratitis. (Barry A Schechter, 2010) Lessens the bacterial load on lid margins and conjunctiva of patients undergoing cataract surgery. (Frank A Bucci, 2015) Has high potency against a broad range of microbial species and a favorable profile in terms of safety and tolerability. (Eduardo Alfonso, 2005)